MEDI 75-Design and synthesis of 3-phenylsulfonylmethyl cyclohexylaminobenzamide-derived inhibitors of CC chemokine receptor 2 (CCR2)

被引：0

作者：

Xiao, Zili ^{[1
]}

Delucca, George V. ^{[1
]}

Cherney, Robert J. ^{[1
]}

Shi, Qing ^{[1
]}

Mo, Ruowei ^{[1
]}

Santella, Joseph B. ^{[1
]}

Tebben, Andrew J. ^{[2
]}

Cvijic, Mary Ellen ^{[3
]}

Zhao, Qihong ^{[4
]}

Barrish, Joel C. ^{[1
]}

Carter, Percy H. ^{[1
]}

Yang, Michael G. ^{[1
]}

机构：

[1] Bristol Myers Squibb Res & Dev, Discovery Chem, Princeton, NJ 08543 USA

[2] Bristol Myers Squibb Co, Comp Assisted Drug Design, Princeton, NJ 08543 USA

[3] Bristol Myers Squibb Co, Lead Evaluat, Res & Dev, Princeton, NJ 08543 USA

[4] Bristol Myers Squibb Co, Immunol Biol, Res & Dev, Princeton, NJ 08543 USA

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2008年 / 236卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

75-MEDI

引用

页数：1

共 50 条

[31] BLOCKADE OF ANGIOTENSIN II TYPE I RECEPTOR (AT1) AND CC CHEMOKINE RECEPTOR 2 (CCR2) HETEROMERS IN PROGRESSIVE CHRONIC KIDNEY DISEASE
Zhang, Y.
Kelly, R.
Cox, A.
Williams, J.
Mccall, L.
Pfleger, K.
Kelly, D.
NEPHROLOGY, 2013, 18 : 36 - 36
[32] High level expression, activation, and antagonism of CC chemokine receptors CCR2 and CCR3 in Chinese hamster ovary cells
Parody, TR
Stone, MJ
CYTOKINE, 2004, 27 (01) : 38 - 46
[33] 2,4-Disubstituted piperidines as selective CC chemokine receptor 3 (CCR3) antagonists: Synthesis and selectivity
Watson, Paul S.
Jiang, Bin
Harrison, Kim
Asakawa, Nao
Welch, Patricia K.
Covington, Maryanne
Stowell, Nicole C.
Wadman, Eric A.
Davies, Paul
Solomon, Kimberly A.
Newton, Robert C.
Trainor, George L.
Friedman, Steven M.
Decicco, Carl P.
Ko, Soo S.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (21) : 5695 - 5699
[34] Molecular structure of a brominated 2-benzazepinone - a crucial intermediate in the synthesis of novel chemokine CCR2 receptor antagonists
Kokornaczyk, Artur K.
Thum, Simone
Daniliuc, Constantin G.
Junker, Anna
Wuensch, Bernhard
ZEITSCHRIFT FUR NATURFORSCHUNG SECTION B-A JOURNAL OF CHEMICAL SCIENCES, 2017, 72 (06): : 421 - 424
[35] Polymorphisms in the CC-chemokine receptor-2 (CCR2) and-5 (CCR5) genes and risk of myocardial infarction among Tunisian male patients
Kallel, Amani
Abdessalem, Salem
Sediri, Yosra
Mourali, Mohamed Sami
Feki, Moncef
Mechmeche, Rachid
Jemaa, Riadh
Kaabachi, Naziha
CLINICAL BIOCHEMISTRY, 2012, 45 (06) : 420 - 424
[36] Design and synthesis of a potent, selective CCR2 receptor antagonist as a potential treatment for atherosclerosis
Wang, Gren Z.
Zhang, Jing
Viet, Andrew Q.
Haile, Pamela A.
Goodman, Krista B.
Dowdell, Sarah E.
Sha, Deyou
Daniel, Thomas
Hughes, Terry V.
Miller, Nathan A.
Miskowski, Tamara A.
Eidam, Hilary S.
Fox, Ryan M.
Lee, Dennis
Evans, Christopher
Gough, Peter
Sehon, Clark A.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 239
[37] Polymorphisms in the CC-chemokine receptor-2 (CCR2) and-5 (CCR5) genes and risk of coronary heart disease among US women
Pai, JK
Kraft, P
Cannuscio, CC
Manson, JE
Rexrode, KM
Albert, CM
Hunter, D
Rimm, EB
ATHEROSCLEROSIS, 2006, 186 (01) : 132 - 139
[38] Retinal Phenotype following Combined Deletion of the Chemokine Receptor CCR2 and the Chemokine CX3CL1 in Mice
Hagbi-Levi, Shira
Grunin, Michelle
Elbaz-Hayoun, Sarah
Tal, David
Obolensky, Alexey
Hanhart, Joel
Banin, Eyal
Burstyn-Cohen, Tal
Chowers, Itay
OPHTHALMIC RESEARCH, 2016, 55 (03) : 126 - 134
[39] Decreased lesion formation in CC chemokine receptor 2 (CCR2) knockout mice reveals an important role for MCP-1 in the development of atherosclerosis
Boring, LF
Gosling, JA
Cleary, MD
Charo, F
CIRCULATION, 1998, 98 (17) : 309 - 309
[40] Chemotaxis of human tonsil B lymphocytes to CC chemokine receptor (CCR) 1, CCR2 and CCR4 ligands is restricted to non-germinal center cells
Corcione, A
Tortolina, G
Bonecchi, R
Battilana, N
Taborelli, G
Malavasi, F
Sozzani, S
Ottonello, L
Dallegri, F
Pistoia, V
INTERNATIONAL IMMUNOLOGY, 2002, 14 (08) : 883 - 892

← 1 2 3 4 5 →